BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6549059)

  • 1. [Effect of exogenous cholinesterase on the pulmonary surfactant system after massive blood loss].
    Zeliak VI; Bazarevich GIa; Norman TN; Leksina AK
    Patol Fiziol Eksp Ter; 1984; (5):8-11. PubMed ID: 6549059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the acetylcholine system on the pathogenesis of pulmonary complications during the postshock period].
    Bazarevich GIa; Abuziarov IG; Kharin GM
    Biull Eksp Biol Med; 1980 Apr; 89(4):403-6. PubMed ID: 6893003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of acute respiratory distress syndrome: role of surfactant changes and mechanical ventilation.
    Verbrugge SJ; Sorm V; Lachmann B
    J Physiol Pharmacol; 1997 Dec; 48(4):537-57. PubMed ID: 9444607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The surfactant system of the lungs in the postoperative period].
    Mustafin AKh; Sinel'nikov AL; Petrova LD
    Anesteziol Reanimatol; 1991; (1):60-3. PubMed ID: 1862971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary megakaryocytes (MK) in experimental hemorrhagic shock].
    Chyczewski L; Debek W
    Patol Pol; 1989; 40(1):29-37. PubMed ID: 2797914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The action of prednisolone on external respiratory function in hemorrhagic shock].
    Matiushin AI; Iakovleva EI; Peretiagin SP
    Farmakol Toksikol; 1990; 53(1):38-40. PubMed ID: 2328797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary surfactant system in respiratory physiology and clinical practice].
    Motles E
    Rev Med Chil; 1973 Jan; 101(1):74-83. PubMed ID: 4800565
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of leukocytes and thrombocytes in lung damage in hemorrhagic shock. Protective effect of aspirin and dipyridamole].
    Zeliak VI
    Patol Fiziol Eksp Ter; 1983; (6):5-8. PubMed ID: 6664699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adult acute respiratory distress syndrome after hemorrhagic shock. Apropos of a case].
    Larabi MS; Mzabi-Regaya S; Mbarek N; Azaïz R; Makni MK; Chadli A; Larabi B
    Tunis Med; 1987 May; 65(5):337-41. PubMed ID: 3505143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Shock lung: general characteristics and pathogenesis].
    Anzalone M
    Torace; 1977 Dec; 20(1-4):15-30. PubMed ID: 583601
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock.
    Murao Y; Loomis W; Wolf P; Hoyt DB; Junger WG
    Shock; 2003 Jul; 20(1):29-34. PubMed ID: 12813365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of surfactant and inhaled nitric oxide in rabbits with surfactant-depleted respiratory failure.
    Zhou BH; Sun B; Zhou ZH; Zhu LW; Fan SZ; Lindwall R
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):691-5. PubMed ID: 10678099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lung as an inflammatory organ.
    Hammerle AF; Tatschl C; Jatzko S; Balcsi R
    Acta Anaesthesiol Scand Suppl; 1997; 111():59-64. PubMed ID: 9420957
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.
    Blanco O; Pérez-Gil J
    Eur J Pharmacol; 2007 Jul; 568(1-3):1-15. PubMed ID: 17543939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of pulmonary recruitment on exogenous surfactant effects].
    Herrera NR; Regnicoli RN; Begnis MS; Scrigna J; Peralta E; Quadrelli L
    Medicina (B Aires); 2006; 66(1):17-23. PubMed ID: 16555723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Artificial reconstituted pulmonary surfactant used for prevention and treatment of adult respiratory distress syndrome. III. Prevention in animal model].
    Jiang ZQ; Ma YM; Xi NZ
    Yao Xue Xue Bao; 1997; 32(2):127-30. PubMed ID: 11243197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene glycol addition does not improve exogenous surfactant function in an experimental model of meconium aspiration syndrome.
    Lyra JC; Mascaretti RS; Precioso AR; Haddad LB; Mauad T; Vaz FA; Rebello CM
    Exp Lung Res; 2009 Feb; 35(1):76-88. PubMed ID: 19191106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.